CBIH

distress 5/10 · elevated risk

$0.000%today-87% from 52w high

2 employeesFounded 2003Houston, TXDrug Manufacturers - Specialty & Generic

Revenue

pre-revenue

Liquidity

$0M

Runway

0.0 yrs

Shares 1y

Price & events

-81.5% over 6M

CatalystRating changeDilutionFinancingdashed = today

+0.0%

-50.0%

-66.7%

-75.0%

-81.5%

-75.0%

-87.5%

-93.3%

-81.8%

All

Overview

Market Cap: $1.16M
Enterprise Value: $1.41M
Volume: 1.53M
52 Week Range: $0.00 – $0.00
Total Shares: 11.63B
Float Shares: 5.08B
% Held by Insiders: 58.41%
% Held by Institutions: 0.00%
RVOL: 0.10x
Beta: 1.41

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 11,626,749,347 · 0 offerings/1y · 0 PIPEs

2025-01-228-Kmaterial_agreement
2024-08-228-Kmaterial_agreement

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified